NEW YORK (GenomeWeb News) – Laboratory Corporation of America today said that its tender offer for all outstanding shares of common stock of Monogram Biosciences expired at midnight last night, and the firm expects to complete its $107 million purchase at the close of business today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.